Vapouround magazine ISSUE 21 - Page 125

2019: a year to watch for CBD W hile CBD has been one of the stories of 2018, the novelty phase is now over, and 2019 will be the year the longer-term future of CBD products becomes clearer. There is every sign of big continued interest in medical and recreational marijuana. And while such products should not be confused with CBD, we can expect some of that interest to rub off on the CBD market. Meanwhile, there is likely to be increased scientific interest in trying to establish how efficacious CBD really is for health, pain-relief and general well- being. Globally 2019 will continue to be a mixed bag for CBD, with growth expected to continue at a rapid pace in established markets while barriers remain in smaller or non-existent ones. Countries such as the UK should continue to see growth. CBD-Intel analysts expect CBD use to become even more wide- spread as it is accepted into more health food stores and mainstream supermarkets. But in other jurisdictions, such as France and Italy, where CBD products have seen greater restrictions, the future does not appear quite as bright. Despite some advances, uncertainty and clampdowns are expected to continue in France. In Italy the story is slightly better. Flowers and foods are expected to see continued restriction but a ministerial decree should add some clarity on foods. And in Spain an increase in enforcement is expected to continue while the country sorts out its CBD regulation. There is mixed news in the Czech Republic. A new proposal for the legalisation of cultivating, handling and using small amounts of low-THC cannabis for personal consumption was given a negative recep- tion by the Czech government during its first reading in the country’s House of Representatives. It is expected that the soon-to-be published national anti-drug strategy for 2019-2027 will mention cannabis in general. However, that does not mean it will deal with CBD. Other countries that have taken a negative approach to CBD are not expected to loosen controls in the near future. CBD-Intel does not predict a market in Russia within the next year, for example. Further afield, countries such as Australia will see slow increases in CBD popularity but levels will depend on future regulation. About CBD-Intel CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector, with a focus on non- US markets. We offer a one-stop source of market and regulatory strategic data for the CBD industry. Providing all the data in one online platform reduces the amount of time and money spent monitoring the sector for multiple international markets. Our global perspective on the international CBD sector offers you key data such as market trends, key players, regulatory obligations and industry dynamics. CBD-Intel’s team is made up of lawyers, economists and journalists. The team is based in London, Barcelona and New York, and enhanced by correspondents and contributors from around the world. In addition, we offer customised research and consultancy support. We also publish ECigIntelligence for the global e-cigarette and tobacco-alternatives sector.